First Annual Rothberg Courage Fund Collaborative Scientific Meeting
October 4th 2002
Meeting Agenda
9:45 Arrive at the Institute
10:00 Introductions - Bonnie Rothberg
10:05 Kick-Off - Jonathan Rothberg
10:15 Tian Xu
"Tsc1/Tsc2
function in the PI3K/Akt pathway and are inhibited by Akt phosphorylation"
10:30 John Blenis
"The
TSC1/TSC2 tumor suppressor complex antagonizes signaling by the
nutrient sensor and cell size regulator mTOR"
10:45 Brendan Manning (Cantley Lab)
"Biochemical
and genetic analyses of the functional relationship between the
PI3K signaling pathway and the TSC gene products"
11:00 Q&A
11:15 Bruce Taillon (CuraGen Corporation)
"A
proteomics approach for exploring the TSC1/2 pathway"
11:30 Amy Kiger (Perrimon Lab)
"Functional
genomics using RNAi screens in drosophila cells"
11:45 Lambert Edelmann (Hariharan Lab)
"Setting
up a cell-based assay in Drosophila for tuberous sclerosis"
12:00 Q&A
12:15 Lunch/ Tour of TRI
13:15 Lisa Henske
"Pulmonary
LAM: A Metastatic Mechanism?"
13:30 David Kwiatkowski
"Advances
in mouse models of TSC"
13:45 John Wheeler & Rachel Squillace (TRI)
"Cell
based screening for drugs to treat Tuberous Sclerosis"
14:00 Q&A
14:15 Tim Mitchison
"Small
molecule screening in academia "
14:30 Wolfgang Hinz (TRI)
"Virtual
Library Screening as a tool in modern drug discovery"
14:45 David Austin
"Small
molecule scaffolds as potential drug leads"
15:00 Q&A
15:15 Next Steps-Round Table Discussion
16:20 Concluding Remarks - Jonathan Rothberg
16:30 Moorings Restaurant - Appetizers & Cocktails
18:00 Adjourn
Pictures
this page last reviewed
|